Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model

Multiple myeloma (MM), a hematological malignancy of plasma cells, has remained incurable despite the development of novel therapies that improve patients’ outcome. Recent evidence indicates that the stimulator of interferon genes (STING) pathway may represent a novel target for induction of antitum...

Descripción completa

Detalles Bibliográficos
Autores principales: Sokolowska, Olga, Rodziewicz-Lurzynska, Anna, Pilch, Zofia, Kedzierska, Hanna, Chlebowska-Tuz, Justyna, Sosnowska, Anna, Szumera-Cieckiewicz, Anna, Sokol, Kamil, Barankiewicz, Joanna, Salomon-Perzynski, Aleksander, Ciepiela, Olga, Lech-Maranda, Ewa, Golab, Jakub, Nowis, Dominika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460740/
https://www.ncbi.nlm.nih.gov/pubmed/36044158
http://dx.doi.org/10.1007/s10238-022-00878-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460740/
https://www.ncbi.nlm.nih.gov/pubmed/36044158
http://dx.doi.org/10.1007/s10238-022-00878-1

Ejemplares similares